Tag Archives: DEL

Top 10 Value Stocks To Invest In Right Now

Asian private equity firm Affinity Equity Partners is nearing a deal to buy Trimco International Holdings Ltd., a Hong Kong-based maker of garment labels, people with knowledge of the matter said.

Affinity was chosen as the preferred bidder for Trimco and will now negotiate final terms of the purchase, according to the people, who asked not to be identified because the information is private. A deal could value Trimco, which is controlled by Partners Group Holding AG, at more than $500 million, one of the people said.

The offer from Affinity trumped bids by Baring Private Equity Asia and Nike Inc. supplier Yue Yuen Industrial Holdings Ltd., which were also among final suitors for Trimco, people with knowledge of the matter said earlier.

Trimco makes clothing care labels, woven labels, hang tags and radio frequency identification tags used for inventory management. Partners Group, the Swiss private equity firm, bought control of the business in 2012. Trimco has production facilities in countries including China, India, Romania, Singapore, Thailand and the U.K.

Top 10 Value Stocks To Invest In Right Now: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

Top 10 Value Stocks To Invest In Right Now: iShares Core S&P 500 (IVV)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    If youre not familiar, the VOO is one of three S&P 500-tracking ETFs the other two are the SPDR S&P 500 ETF Trust (SPY) and the iShares Core S&P 500 ETF (IVV). Each operates slightly differently, but at the end of the day, each provides very honest, tight tracking of the S&P 500. The VOO is simply the cheapest at just 0.05% in expenses, which accounts for most of the slight performance edge over its ETF brethren.

  • [By Todd Shriber, ETF Professor]

    Passive ETFs continuing to top active rivals is not all about the performance of U.S. stocks this year. Yes, the S&P 500 is up 5.5 percent year-to-date, but that is not a jaw-dropping performance. Much of the ongoing out-performance of passive ETFs over active counterparts this year is attributable to fees. Just look at the rock-bottom fees on ETFs such as the SPDR S&P 500 ETF (NYSE: SPY) and the iShares S&P 500 Core ETF (NYSE: IVV).

  • [By WWW.GURUFOCUS.COM]

    For the details of SWISS RE LTD’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=SWISS+RE+LTD

    These are the top 5 holdings of SWISS RE LTDiShares Core S&P 500 (IVV) – 1,274,000 shares, 41.43% of the total portfolio. Shares added by 114.84%SPDR S&P 500 (SPY) – 1,192,350 shares, 38.52% of the total portfolio. Shares added by 158.64%iShares MSCI EAFE (EFA) – 1,043,001 shares, 8.7% of the total portfolio. Shares added by 12.39%iShares Floating Rate Bond (FLOT) – 1,000,000 shares, 7.33% of the total portfolio. NewStar Financial Inc (NEWS) – 3,000,000 shares, 4.01%

Top 10 Value Stocks To Invest In Right Now: Golfsmith International Holdings Inc.(GOLF)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap golf equipment stockAcushnet Holdings Corp (NYSE: GOLF):

    Acushnet Holdings has been on our watchlist for a while too, but it’s only been in the past few days we’ve seen the cracks start to appear.

  • [By Shane Hupp]

    DA Davidson reissued their hold rating on shares of Acushnet (NYSE:GOLF) in a research note published on Monday.

    A number of other research analysts have also issued reports on the stock. Morgan Stanley reiterated an overweight rating on shares of Acushnet in a report on Thursday, March 8th. ValuEngine upgraded shares of Acushnet from a hold rating to a buy rating in a report on Thursday, February 8th. SunTrust Banks reiterated a buy rating and issued a $26.00 price objective on shares of Acushnet in a report on Wednesday, April 11th. Compass Point lowered shares of Acushnet from a buy rating to a neutral rating and set a $24.00 price objective for the company. in a report on Monday, March 19th. Finally, KeyCorp reiterated an overweight rating on shares of Acushnet in a report on Thursday, March 8th. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of Buy and a consensus target price of $23.40.

Top 10 Value Stocks To Invest In Right Now: SuperValu Inc.(SVU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    SuperValu (NYSE:SVU) – Northcoast Research issued their Q1 2019 earnings per share estimates for SuperValu in a note issued to investors on Wednesday, May 9th. Northcoast Research analyst C. Cerankosky expects that the company will earn $0.65 per share for the quarter. Northcoast Research also issued estimates for SuperValu’s Q2 2019 earnings at $0.55 EPS, Q3 2019 earnings at $0.30 EPS, Q4 2019 earnings at $0.54 EPS and FY2019 earnings at $2.04 EPS.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, SUPERVALU (NYSE:SVU) and MSC Industrial (NYSE:MSM) stood out with big pricing moves after announcing quarterly business updates.

  • [By Peter Graham]

    Small cap grocery store stock SUPERVALU Inc (NYSE: SVU) reported Q1 2018 earnings this morning before the market opened with shares up more than 14% as Wholesale business results were outstanding. Net salesincreased 6.3% to$4.00 billion as Retail net sales were down 2.7% to $1.39 billion with the decrease reflecting identical store sales of negative 4.9% and closed stores, partially offset by sales from acquired and new stores.Total net sales within the Wholesale segment increased 12.4% to $2.56 billion primarily due to sales to new customers and increased sales to new stores operated by existing customers, partially offset by stores no longer being supplied by Supervalu and lower military sales. Retail identical store sales were negative 4.9% while fees earned under services agreements in the first quarter were $55 million versus $59 million last year. Net earnings from continuing operations was $12 million versus $20 million. The CEO commented:

  • [By Casey Wilson]

    Big grocery and supermarket chain stocks plummeted on June 16 when the deal was announced. Kroger Co. (NYSE: KR) sunk over 9.2%, Supervalu Inc. (NYSE: SVU) dropped 14.4%, and Wal-Mart Stores Inc. (NYSE: WMT) lost 4.7%. Meanwhile, AMZN enjoyed a nice 2.44% gain.

  • [By Jon C. Ogg]

    SUPERVALU Inc. (NYSE: SVU) was raised to Outperform from Sector Perform at RBC Capital Markets. Shares were indicated up 6% at $3.54 on Thursday.

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was indicated down 7% at $72.85 on Thursday due to results from a seizure medication study. It was downgraded to Neutral from Overweight at Piper Jaffray, and Wedbushlowered its target for the stock.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, RetailMeNot (NASDAQ:SALE) and SUPERVALU (NYSE:SVU) attracted heavy investor interest following merger and acquisition news.

Top 10 Value Stocks To Invest In Right Now: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.

  • [By Ben Levisohn]

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

  • [By Casey Wilson]

    Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”

    The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.

  • [By Casey Wilson]

    Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.

  • [By Johanna Bennett]

    Times are tough for Ralph Lauren (RL). Profit and sales are fallingat theiconic clothingcompany, and investors who bet on a turnaround havelost their shirts on the stock. Adding to its troubles,CEO StefanLarsson is departingfollowing a creative clash with the companys namesake and founder.

    Pessimism, meanwhile, appears to be on the rise.

    According to a report by the financial analytics company S3 Partners, short interest in Ralph Lauren has risen since the start of the year, hitting historical levels. And while that short position is expected to keep expanding, bearish sentiments could turn on a dime.

    Ihor Dusaniwsky at S3 Partners writes:

    RL short interest levels, already at historical highs today, should continue to grow if the recent trend continues, but having made almost 23% in 2016 and 14% in 2017, short sellers may be quick to cover their positions and lock in profits if RLs stock price turns against them.

    Short interest in Ralph Lauren fell in 2016 as the stock price fella nd shorts covered positions, netting a return of 22.6%. So far this year, however, the short position as increased $226 million, or 38% to $815 million as of this morning, according to the S3 report.

    Its a profitable day for those short sellers. Todays 11% decline Ralph Laurens stock price on an $815 million short position has added $90 million to the short sellers collective bottom line.

    Ralph Lauren is down 11.5% in recent market actions to $77.26 a after earlier falling as low as $76.86 a share. Thats the lowest price for the stock since 2010.

Top 10 Value Stocks To Invest In Right Now: The First of Long Island Corporation(FLIC)

Advisors’ Opinion:

  • [By Dividends4Life]

    The First of Long Island Corporation (FLIC) operates as a bank holding company for The First National Bank of Long Island that provides financial services. Sept. 19, the company increased its quarterly dividend 4% to $0.26 per share. The dividend is payable Oct. 11, 2013 to shareholders of record on October 3, 2013. The yield based on the new payout is 2.7%.

Top 10 Value Stocks To Invest In Right Now: BAE Systems PLC (BAESY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Rheinmetall is currently trading at 15.7x forward earnings and 2.5x book value, a valuation that is closer to its automotive suppliers peers. Compared to its defense peers, its valuation is clearly cheap, as shown in the next table. This shows that Rheinmetall is usually benchmarked against its auto peers, even though 53% of its sales and 41% of operating income have come from its defense unit in the past year.

    P/E P/BV Rheinmetall 15.7 2.5 Continental AG 12.4 2.9 Valeo 13.1 3.6 Brembo (OTC:BRBOF) 17.0 5.2 Leoni (OTC:LNNNY) 13.2 1.9 Auto Peers Average 14.3 3.2 Airbus 24.0 6.8 Leonardo 16.8 2.0 BAE Systems (OTCPK:BAESY) 18.5 5.7 Thales (OTCPK:THLEY) 22.4 4.3 Defense Sector Average 19.2 4.4

    Source: Bloomberg

  • [By WWW.THESTREET.COM]

    BAE Systems (BAESY) and other defense stocks gained on Friday morning after President Donald Trump’s strike on Syria prompted investors to consider the possibility of greater Western involvement in the Syrian conflict.

Top 10 Value Stocks To Invest In Right Now: Cliffs Natural Resources Inc.(CLF)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares rose by 0.74 percent in the US market on Friday. Top gainers in the sector included AK Steel Holding Corporation (NYSE: AKS), Cliffs Natural Resources Inc (NYSE: CLF), and United States Steel Corporation (NYSE: X).

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 1.99 percent. Meanwhile, top losers in the sector included Cliffs Natural Resources Inc (NYSE: CLF), down 9 percent, and AK Steel Holding Corporation (NYSE: AKS), down 9 percent.

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin]

    Thursday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from United States Steel Corporation (NYSE: X) and Cliffs Natural Resources Inc (NYSE: CLF).

  • [By Tyler Crowe]

    No matter how much a commodity company like Cliffs Natural Resources (NYSE:CLF) tries, its fate will almost exclusively be in the hands of commodity prices. In the case of this past quarter, Cliffs was dealt a tougher hand as iron ore prices declined again. That may be enough to get some investors to head for the hills, but there were also some very promising signs that the company is setting itself up for a better long-term future.

Top 10 Value Stocks To Invest In Right Now: Deltic Timber Corporation(DEL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Top 10 Value Stocks To Invest In Right Now: Extra Space Storage Inc(EXR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Extra Space Storage, Inc. (NYSE:EXR) hit a new 52-week high and low during trading on Tuesday . The company traded as low as $93.95 and last traded at $93.32, with a volume of 318074 shares changing hands. The stock had previously closed at $93.44.

  • [By Jon C. Ogg]

    Extra Space Storage Inc. (NYSE: EXR) was raised to Buy from Neutral at Merrill Lynch.

    ALSO READ: Jefferies Analysts Out With Top Stock Picks Before Global Tech Conference

    Goodyear Tire & Rubber Co. (NYSE: GT) was reiterated as Buy with a $36 price target (versus a $25.16 close) at Argus. The firm noted that the recent sell-off offers an attractive entry point.

  • [By Matthew Frankel]

    The final REIT type I like right now is self-storage, particularly Extra Space Storage (NYSE:EXR).

    First, I should mention that this could prove to be the most volatile company on the list. Self-storage isn’t as defensive as retail or healthcare simply because of its lease structure. Generally, you don’t sign a multi-year lease on a storage unit — you just pay each month that you want to keep it. This makes it easier for tenants to vacate the properties during tough times.

Hot Performing Stocks To Invest In Right Now

March 20, 2017: Markets opened slightly lower Monday and traded close to the break-even line all day. Leading indicators and consumer sentiment readings were both strong. Only the materials sector traded high late in the afternoon while energy and utilities were the laggards. The blue chips were performing best. WTI crude oil for April delivery settled at $48.22 a barrel, down 1.2% on the day. April gold added 0.3% on the day to settle at $1,234.00. Equities were headed for a mixed close shortly before the bell as the DJIA traded up 0.03% for the day, the S&P 500 traded down 0.14%, and the Nasdaq Composite traded up 0.02%.

Stocks traded very near the break-even line just minutes before the closing bell. The closing tally could finish with either a small gain or a small loss for any or all of the indexes.

The DJIA stock posting the largest daily percentage gain ahead of the close Monday was Caterpillar Inc. (NYSE: CAT) which traded up 2.66% at $95.38. The stock’s 52-week range is $69.04 to $99.46. Volume was roughly 15% below the daily average of around 5 million shares. The company reported a 1% decline in February retail sales this morning, the best year-over-year mark in more than 4 years.

Hot Performing Stocks To Invest In Right Now: Daktronics, Inc.(DAKT)

Advisors’ Opinion:

  • [By Monica Gerson]

    Daktronics, Inc. (NASDAQ: DAKT) is estimated to report its quarterly earnings at $0.08 per share on revenue of $156.17 million. Daktronics shares slipped 0.13 percent to close at $7.97 on Tuesday.

  • [By Monica Gerson]

    Daktronics, Inc. (NASDAQ: DAKT) is projected to report its quarterly earnings at $0.08 per share on revenue of $156.17 million.

    Guidewire Software Inc (NYSE: GWRE) is estimated to post its quarterly earnings at $0.06 per share on revenue of $92.43 million.

Hot Performing Stocks To Invest In Right Now: Deltic Timber Corporation(DEL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Hot Performing Stocks To Invest In Right Now: Cubic Corporation(CUB)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    In actuality, we think the reverse is true for several reasons. We believe that there is a higher level of investor neglect in the small cap space, and neglect, in an investment sense, creates valuation discounts from fair value. Small cap names are less well-known and understood. For example, most of you have never heard of Cubic Corporation (NYSE:CUB), but you have likely used the public transportation systems in New York, London, Sydney, etc. that rely on Cubic for fare collection services. Likewise, Multi-Color is a confusing name for the second largest label maker in the world. To understand these businesses, investors need to dig a little deeper with active fundamental research – a Third Avenue strength.

  • [By Lisa Levin]

    Cubic Corporation (NYSE: CUB) shares were also up, gaining 15 percent to $61.45. Cubic reported Q4 net income of $13.2 million, after posting a loss in the year-ago period. Cubic also disclosed that it has been selected for contract from Boston MBTA to deliver next-generation fare payment system.

  • [By Jim Robertson]

    On Friday, small cap Cubic Corporation (NYSE: CUB) had closed up 10.26% with shares rising again in early Monday trading. Cubic Corporation designs, integrates and operates systems, products and services focused in the transportation, defense training and secure communications markets. As the parent company of two major business units,the Companysmission is to increase situational awareness and understanding for customers worldwide. Cubic Transportation Systems is a leading integrator of payment and information technology and services to create intelligent travel solutions for public transit authorities and operators whileCubic Global Defense is a leading provider of realistic combat training systems, secure communications and networking and highly specialized support services for military and security forces of the U.S. and allied nations.

Hot Performing Stocks To Invest In Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Novocure Ltd (NASDAQ: NVCR) shares shot up 22 percent to $7.27 after the company posted a narrower-than-expected Q3 loss.

    Shares of TriNet Group Inc (NYSE: TNET) got a boost, shooting up 15 percent to $20.43. TriNet reported Q3 earnings of $0.29 per share on revenue of $770.5 million.

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.

Hot Performing Stocks To Invest In Right Now: Biotricity (BTCY)

Advisors’ Opinion:

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By James E. Brumley]

    Biotricity Inc (OTCMKTS:BTCY), a developer of remote health-monitoring devices, reminded us not so gently today that while it’s waiting on the last of the necessary approvals from the FDA for its hardware, it’s still moving the ball downfield (so to speak). That is to say, it’s already lined up a manufacturer for its so-called Bioflux cardiac monitor for when the last green light is given, and it’s a good one…. Providence Enterprise . That’s the same company that makes some of the equipment and goods within your sight right now.

    Biotricity is the name behind two pieces of technology, both of which are nearing the end of their development. One is the aforementioned Bioflux, and the other is called biolife…. the latter for use by individuals outside of a clinical setting. Neither is on the market yet, but both are projected to be on the market this year. In fact, the company demonstrated its IoT-connected bioflux at this year’s Mobile World Congress (MWC) 2017 in Barcelona, Spain a couple of weeks ago. The crowd liked what it saw.

    The marketable version of the device isn’t available yet; it’s still going through the approval process. The company recently filed a 510k request with the FDA for its bioflux technology (the 510k path is for medical devices rather than drugs, and as such doesn’t require a lot of regulatory deliberation), and has heard back from the FDA about a key part of the device already – it got the green light. Another arm of the FDA must look at other aspects of the device, and that portion of the review takes longer.

    Still, the company is rightfully optimistic, so much so that it’s already lined up a company to manufacture the Bioflux device once the final approval and final specs are in. That company is Providence Enterprise, which has a long history in making drug delivery and diagnostic equipment, as well as plenty of experience making electronics. The Bioflux will be a blend of both capabilities.

    It’s in

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Robert J. Smith]

    Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.

  • [By Bryan Murphy]

    As much progress as the remote medical monitoring device market has made in recent years, we’ve still only scratched the surface. The surface has been scratched though. The Dexcom G5 mobile glucose monitor from DexCom, Inc. (NASDAQ:DXCM) is one impressive example. Arguably the first and best entry in the race, DexCom has sent a clear message that consumers and caregivers are ready for a functional device that takes care of itself.

    At the other end of the spectrum is a recent round of products that are less clinical in nature, and more broad-usage friendly. Devices like the Apple Inc. (NASDAQ:AAPL) watch and the Fitbit Inc (NYSE:FIT) line of products are both capable of monitoring heart rates and activity. On the other, neither does it all that well… not like one would expect in a clinical setting. Fitbit has run into a headwind of legal and reputational trouble since it’s been verified that its trackers aren’t all that accurate; Apple avoided such trouble largely because few consumers ever viewed its watches as medical-grade hardware.

    The gap between the Dexcom G5 and the Fitbit fitness trackers, however, is where real opportunity lies. See, the entries to date have proven there is a market for mobile medical devices , but have also proven they have to work as well as the equipment one might expect to find in a doctor’s office or in a hospital.

    It’s this subtle nuance that puts a young company called Biotricity Inc. (OTCMKTS:BTCY) in the spotlight, as it has melded mobile monitoring and quality monitoring, and is now in the midst of making sure they’re marketable… not just to consumers, but to insurance companies (which tend to pay a lot more than the average consumer does). Fitbit missed the mark on both fronts.

    Biotricity is working two different but similar pieces of technology. One is called bioflux, for use by caregivers in a clinical setting, and the other is biolife individuals outside of a clinical setting. Neither is o

Hot Performing Stocks To Invest In Right Now: International Paper Company(IP)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on T-Mobile US (TMUS) , Lennar (LEN) , Toll Brothers (TOL) , Tyson Foods (TSN) , JB Hunt Transport Services (JBHT) and International Paper (IP) .

  • [By WWW.KIPLINGER.COM]

    International Paper Co. (IP) is the largest containerboard maker in the world. And lest you think theres no growth in this old-line industry, IP supplies 50% of Amazon.com, Inc.s (AMZN) need for cardboard boxes.

  • [By ]

    International Paper (IP) : “The stock is down big. I say at these prices it’s a good buy.”

    Alaska Air Group (ALK) : “It used to be the best before the acquisition and now it’s not great and I can’t recommend it anymore.”